3
Announcements
Trials
Browse
Landscape
Status
Unknown
4
Completed
3
Recruiting
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Motor Activity
22
Breast Neoplasms
14
Neoplasms
9
Fatigue
5
Prostatic Neoplasms
4
Obesity
4
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Peripheral Nervous System Diseases
2
Overweight
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lung Neoplasms
2
Cognitive Dysfunction
2
Cardiovascular Diseases
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Smoking
1
Skin Neoplasms
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Osteolysis
1
Non-alcoholic Fatty Liver Disease
1
Neuroectodermal Tumors, Primitive
1
Neurocognitive Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Interventions
fludarabine
6
trametinib
5
Specimen Handling
5
Standard of Care
4
Practice Guidelines as Topic
4
Magnetic Resonance Spectroscopy
4
fludarabine phosphate
3
Whole-Body Irradiation
3
Mycophenolic Acid
3
Melphalan
3
Interviews as Topic
3
GSK2636771
3
Cyclophosphamide
3
Crizotinib
3
Busulfan
3
Biopsy
3
Antilymphocyte Serum
3
AP 1903 reagent
3
venetoclax
2
thymoglobulin
2
palbociclib
2
osimertinib
2
letermovir
2
dabrafenib
2
capivasertib
2
binimetinib
2
adavosertib
2
X-Rays
2
Thiotepa
2
Tacrolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Hematologic Neoplasms
×
Exercise
×
Clear all
NCT06102876
2025-04-10
ACCES
University Hospital, Toulouse
Active not recruiting
69 enrolled